loadpatents
Patent applications and USPTO patent grants for LEADBETTER; Michael R..The latest application filed is for "compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt".
Patent | Date |
---|---|
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt App 20190374533 - CHARMOT; Dominique ;   et al. | 2019-12-12 |
Compounds And Methods For Inhibiting Phosphate Transport App 20170037010 - Lewis; Jason G. ;   et al. | 2017-02-09 |
Compounds and methods for inhibiting phosphate transport Grant 9,301,951 - Lewis , et al. April 5, 2 | 2016-04-05 |
Compounds and methods for inhibiting phosphate transport Grant 9,289,429 - Lewis , et al. March 22, 2 | 2016-03-22 |
Compounds and methods for inhibiting phosphate transport Grant 9,289,430 - Lewis , et al. March 22, 2 | 2016-03-22 |
Compounds and methods for inhibiting phosphate transport Grant 9,278,102 - Lewis , et al. March 8, 2 | 2016-03-08 |
Compounds And Methods For Inhibiting Phosphate Transport App 20150164876 - Lewis; Jason G. ;   et al. | 2015-06-18 |
Compounds And Methods For Inhibiting Phosphate Transport App 20150164904 - Lewis; Jason G. ;   et al. | 2015-06-18 |
Compounds And Methods For Inhibiting Phosphate Transport App 20150164905 - Lewis; Jason G. ;   et al. | 2015-06-18 |
Compounds And Methods For Inhibiting Phosphate Transport App 20150157637 - Lewis; Jason G. ;   et al. | 2015-06-11 |
3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists Grant 8,969,370 - Trapp , et al. March 3, 2 | 2015-03-03 |
Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists Grant 8,952,031 - Trapp , et al. February 10, 2 | 2015-02-10 |
Compounds and methods for inhibiting phosphate transport Grant 8,916,569 - Lewis , et al. December 23, 2 | 2014-12-23 |
3-carboxypropyl-aminotetralin Derivatives And Related Compounds As Mu Opioid Receptor Antagonists App 20140329845 - Trapp; Sean G. ;   et al. | 2014-11-06 |
Glycopeptide phosphonate derivatives Grant 8,859,506 - Leadbetter October 14, 2 | 2014-10-14 |
Compounds and methods for inhibiting phosphate transport Grant 8,815,908 - Lewis , et al. August 26, 2 | 2014-08-26 |
Compounds and methods for inhibiting phosphate transport Grant 8,815,910 - Lewis , et al. August 26, 2 | 2014-08-26 |
Compounds and methods for inhibiting phosphate transport Grant 8,809,339 - Lewis , et al. August 19, 2 | 2014-08-19 |
3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists Grant 8,703,791 - Trapp , et al. April 22, 2 | 2014-04-22 |
3-carboxypropyl-aminotetralin Derivatives And Related Compounds As Mu Opioid Receptor Antagonists App 20140031380 - Trapp; Sean G. ;   et al. | 2014-01-30 |
Compounds And Methods For Inhibiting Phosphate Transport App 20140023611 - Lewis; Jason G. ;   et al. | 2014-01-23 |
Glycopeptide Phosphonate Derivatives App 20140024604 - Leadbetter; Michael R. | 2014-01-23 |
Compounds And Methods For Inhibiting Phosphate Transport App 20130336921 - Lewis; Jason G. ;   et al. | 2013-12-19 |
Compounds And Methods For Inhibiting Phosphate Transport App 20130336920 - Lewis; Jason G. ;   et al. | 2013-12-19 |
Compounds And Methods For Inhibiting Phosphate Transport App 20130336919 - Lewis; Jason G. ;   et al. | 2013-12-19 |
Compounds And Methods For Inhibiting Phosphate Transport App 20130336918 - Lewis; Jason G. ;   et al. | 2013-12-19 |
Glycopeptide phosphonate derivatives Grant 8,541,375 - Leadbetter September 24, 2 | 2013-09-24 |
Aminotetralin compounds as mu opioid receptor antagonists Grant 8,497,287 - Leadbetter , et al. July 30, 2 | 2013-07-30 |
3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists Grant 8,492,399 - Leadbetter , et al. July 23, 2 | 2013-07-23 |
Aminotetralin Compounds As Mu Opioid Receptor Antagonists App 20130040965 - Leadbetter; Michael R. ;   et al. | 2013-02-14 |
3-carboxypropyl-aminotetralin Derivatives And Related Compounds As Mu Opioid Receptor Antagonists App 20130035510 - Leadbetter; Michael R. ;   et al. | 2013-02-07 |
3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists Grant 8,318,765 - Trapp , et al. November 27, 2 | 2012-11-27 |
Aminotetralin compounds as mu opioid receptor antagonists Grant 8,314,128 - Leadbetter , et al. November 20, 2 | 2012-11-20 |
Glycopeptide Phosphonate Derivatives App 20120283195 - Leadbetter; Michael R. ;   et al. | 2012-11-08 |
Amino- And Amido-aminotetralin Derivatives And Related Compounds As Mu Opioid Receptor Antagonists App 20120165360 - Trapp; Sean G. ;   et al. | 2012-06-28 |
3-carboxypropyl-aminotetralin Derivatives And Related Compounds As Mu Opioid Receptor Antagonists App 20120088787 - Trapp; Sean G. ;   et al. | 2012-04-12 |
Aminotetralin Compounds As Mu Opioid Receptor Antagonists App 20120088794 - Leadbetter; Michael R. ;   et al. | 2012-04-12 |
Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists Grant 8,153,686 - Trapp , et al. April 10, 2 | 2012-04-10 |
3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists Grant 8,106,232 - Trapp , et al. January 31, 2 | 2012-01-31 |
Aminotetralin compounds as mu opioid receptor antagonists Grant 8,101,791 - Leadbetter , et al. January 24, 2 | 2012-01-24 |
Glycopeptide phosphonate derivatives Grant 8,101,575 - Leadbetter January 24, 2 | 2012-01-24 |
Process for preparing glycopeptide phosphonate derivatives Grant 8,093,354 - Leadbetter , et al. January 10, 2 | 2012-01-10 |
Glycopeptide derivative Grant 8,030,445 - Leadbetter October 4, 2 | 2011-10-04 |
Process For Preparing Glycopeptide Phosphonate Derivatives App 20110060122 - Leadbetter; Michael R. ;   et al. | 2011-03-10 |
Glycopeptide Phosphonate Derivatives App 20100160211 - Leadbetter; Michael R. ;   et al. | 2010-06-24 |
Process for preparing glycopeptide phosphonate derivatives Grant 7,728,104 - Leadbetter , et al. June 1, 2 | 2010-06-01 |
Glycopeptide derivatives and pharmaceutical compositions containing the same Grant 7,723,470 - Judice , et al. May 25, 2 | 2010-05-25 |
Glycopeptide phosphonate derivatives Grant 7,700,550 - Leadbetter April 20, 2 | 2010-04-20 |
Amino- And Amido-aminotetralin Derivatives And Related Compounds As Mu Opioid Receptor Antagonists App 20090247627 - Trapp; Sean G. ;   et al. | 2009-10-01 |
Aryl aniline .beta..sub.2 adrenergic receptor agonists Grant 7,582,765 - Moran , et al. September 1, 2 | 2009-09-01 |
Glycopeptide Derivatives And Pharmaceutical Compositions Containing The Same App 20090215982 - Judice; J. Kevin ;   et al. | 2009-08-27 |
Aryl aniline .beta.2 adrenergic receptor agonists Grant 7,553,971 - Moran , et al. June 30, 2 | 2009-06-30 |
3-carboxypropyl-aminotetralin Derivatives And Related Compounds As Mu Opioid Receptor Antagonists App 20090149535 - Trapp; Sean G. ;   et al. | 2009-06-11 |
Aminotetralin Compounds As Mu Opioid Receptor Antagonists App 20090149465 - Leadbetter; Michael R. ;   et al. | 2009-06-11 |
Glycopeptide phosphonate derivatives App 20080312407 - Leadbetter; Michael R. ;   et al. | 2008-12-18 |
Process for preparing glycopeptide phosphonate derivatives App 20080227963 - Leadbetter; Michael R. ;   et al. | 2008-09-18 |
Cross-linked glycopeptide-cephalosporin antibiotics Grant 7,405,199 - Marquess , et al. July 29, 2 | 2008-07-29 |
Glycopeptide derivatives and pharmaceutical compositions containing the same App 20080103292 - Judice; J. Kevin ;   et al. | 2008-05-01 |
Glycopeptide phosphonate derivatives Grant 7,351,691 - Leadbetter , et al. April 1, 2 | 2008-04-01 |
Process for preparing glycopeptide phosphonate derivatives Grant 7,301,004 - Leadbetter , et al. November 27, 2 | 2007-11-27 |
Aryl aniline beta2 adrenergic receptor agonists App 20070225329 - Moran; Edmund J. ;   et al. | 2007-09-27 |
Glycopeptide carboxy-saccharide derivatives Grant 7,265,086 - Linsell , et al. September 4, 2 | 2007-09-04 |
Glycopeptide phosphonate derivatives Grant 7,208,471 - Leadbetter April 24, 2 | 2007-04-24 |
Glycopeptide phosphonate derivatives App 20070049519 - Leadbetter; Michael R. | 2007-03-01 |
Glycopeptide carboxy-saccharide derivatives App 20070042942 - Linsell; Martin S. ;   et al. | 2007-02-22 |
Glycopeptide carboxy-saccharide derivatives Grant 7,157,554 - Linsell , et al. January 2, 2 | 2007-01-02 |
Process for preparing glycopeptide phosphonate derivatives App 20060264607 - Leadbetter; Michael R. ;   et al. | 2006-11-23 |
Aryl aniline beta2 adrenergic receptor agonists App 20060178410 - Moran; Edmund J. ;   et al. | 2006-08-10 |
Process for preparing glycopeptide phosphonate derivatives Grant 7,074,890 - Leadbetter , et al. July 11, 2 | 2006-07-11 |
Glycopetide phosphonate derivatives App 20060063706 - Leadbetter; Michael R. ;   et al. | 2006-03-23 |
Glycopeptide phosphonate derivatives Grant 7,008,923 - Leadbetter , et al. March 7, 2 | 2006-03-07 |
Cross-linked glycopeptide-cephalosporin antibiotics App 20060025332 - Marquess; Daniel ;   et al. | 2006-02-02 |
Process for preparing glycopeptide phosphonate derivatives Grant 6,979,723 - Leadbetter , et al. December 27, 2 | 2005-12-27 |
Glycopeptide derivatives and pharmaceutical compositions containing the same Grant 6,962,970 - Judice , et al. November 8, 2 | 2005-11-08 |
Novel Antibacterial Agents App 20050171010 - Chen, Qi-Qi ;   et al. | 2005-08-04 |
Glycopeptide phosphonate derivatives App 20050164916 - Leadbetter, Michael R. ;   et al. | 2005-07-28 |
Glycopeptide carboxy-saccharide derivatives App 20050159344 - Linsell, Martin S. ;   et al. | 2005-07-21 |
Glycopeptide carboxy-saccharide derivatives Grant 6,903,070 - Linsell , et al. June 7, 2 | 2005-06-07 |
Glycopeptide phosphonate derivatives Grant 6,887,976 - Leadbetter , et al. May 3, 2 | 2005-05-03 |
Glycopeptide phosphonate derivatives Grant 6,872,701 - Leadbetter , et al. March 29, 2 | 2005-03-29 |
Process for preparing glycopeptide phosphonate derivatives App 20050020488 - Leadbetter, Michael R. ;   et al. | 2005-01-27 |
Glycopeptide carboxy-saccharide derivatives App 20040087494 - Linsell, Martin S. ;   et al. | 2004-05-06 |
Aryl aniline beta2 adrenergic receptor agonists App 20040063755 - Moran, Edmund J. ;   et al. | 2004-04-01 |
Glycopeptide phosphonate derivatives App 20040063916 - Leadbetter, Michael R. ;   et al. | 2004-04-01 |
Aryl aniline .beta.2 adrenergic receptor agonists Grant 6,670,376 - Moran , et al. December 30, 2 | 2003-12-30 |
Aryl aniline beta2 adrenergic receptor agonists App 20030229058 - Moran, Edmund J. ;   et al. | 2003-12-11 |
Glycopeptide phosphonate derivatives App 20030207797 - Leadbetter, Michael R. ;   et al. | 2003-11-06 |
Glycopeptide phosphonate derivatives Grant 6,635,618 - Leadbetter , et al. October 21, 2 | 2003-10-21 |
Glycopeptide carboxy-saccharide derivatives Grant 6,620,781 - Linsell , et al. September 16, 2 | 2003-09-16 |
Process for preparing glycopeptide phosphonate derivatives App 20030069391 - Leadbetter, Michael R. ;   et al. | 2003-04-10 |
Glycopeptide derivatives and pharmaceutical compositions containing the same App 20030060598 - Judice, J. Kevin ;   et al. | 2003-03-27 |
Multibinding inhibitors of HMG-CoA reductase Grant 6,355,810 - Griffin , et al. March 12, 2 | 2002-03-12 |
Glycopeptide carboxy-saccharide derivatives App 20020028770 - Linsell, Martin S. ;   et al. | 2002-03-07 |
Glycopeptide phosphonate derivatives App 20020022590 - Leadbetter, Michael R. ;   et al. | 2002-02-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.